C.J. Ryerson
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Inhalation and Respiratory Drug Delivery
- Respiratory Support and Mechanisms
- Pulmonary Hypertension Research and Treatments
- Respiratory and Cough-Related Research
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
- Medical Imaging and Pathology Studies 2
- Pulmonary Hypertension Research and Treatments 2
-
- Sarcoidosis and Beryllium Toxicity Research 2
- Co-authors
- Francesco Bonella (1 shared paper)Paolo Spagnolo (1 shared paper)Jessica A. Inskip (1 shared paper)Alison M. Hoens (1 shared paper)Guy A. Dumont (1 shared paper)Linda Li (1 shared paper)Jeremy Road (1 shared paper)Pat G. Camp (1 shared paper)
- Journals
- Global Spine Journal (1 paper)Drugs (1 paper)Frontiers in Medicine (1 paper)CHEST Journal (1 paper)Chronic Respiratory Disease (1 paper)
- Partner nations
- CanadaGermanyUnited States
In The Last Decade
C.J. Ryerson
9 papers receiving 172 citations
C.J. Ryerson's Hit Papers
Peers
Comparison fields: 5 of 54
- Pulmonary and Respiratory Medicine 133
- Issues, ethics and legal aspects 3
- Geriatrics and Gerontology 5
- Physiology 25
- Public Health, Environmental and Occupational Health 27
Countries citing papers authored by C.J. Ryerson
This map shows the geographic impact of C.J. Ryerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J. Ryerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J. Ryerson more than expected).
Fields of papers citing papers by C.J. Ryerson
This network shows the impact of papers produced by C.J. Ryerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J. Ryerson. The network helps show where C.J. Ryerson may publish in the future.
Co-authors
The 25 scholars most cited alongside C.J. Ryerson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2023 | 76 |
| 2 | 2015 | 32 | |
| 3 | 2017 | 32 | |
| 4 | 2020 | 18 | |
| 5 | 2016 | 5 | |
| 6 | 2023 | 4 | |
| 7 | 2018 | 3 | |
| 8 | 2004 | 3 | |
| 9 | 2021 | 1 | |
| 10 | 2025 | 0 | |
| 11 | 2017 | 0 | |
| 12 | 2022 | 0 |
About C.J. Ryerson
C.J. Ryerson is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Surgery, Pathology and Forensic Medicine and Neurology, having authored 12 papers that have together received 174 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Long-Term Effects of COVID-19 (2 papers), Medical Imaging and Pathology Studies (2 papers), Systemic Sclerosis and Related Diseases (2 papers), Pulmonary Hypertension Research and Treatments (2 papers), Sarcoidosis and Beryllium Toxicity Research (2 papers) and Dysphagia Assessment and Management (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (133 citations), Issues, ethics and legal aspects (3 citations), Geriatrics and Gerontology (5 citations), Physiology (25 citations) and Public Health, Environmental and Occupational Health (27 citations). C.J. Ryerson has collaborated with scholars based in Canada, Germany and United States. Frequent co-authors include Francesco Bonella, Paolo Spagnolo, Jessica A. Inskip, Alison M. Hoens, Guy A. Dumont, Linda Li, Jeremy Road, Pat G. Camp, Helen Novak Lauscher and Ainara Garde. Their work appears in journals such as Global Spine Journal, Drugs, Frontiers in Medicine, CHEST Journal and Chronic Respiratory Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.